Evidence map›Paper›PMID 21111996›Full record

ReviewClinics in liver disease2011

Infectious diseases and the liver.

Rohit Talwani, Bruce L Gilliam, Charles Howell

Abstract readReview
In one paragraph

Review in Clinics in liver disease, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. bioRxiv : the preprint server for biology · 2026
    Article
  4. Journal of translational autoimmunity · 2025
    Article
  5. Hepatic involvement in major respiratory viral infections.Clinical and experimental hepatology · 2025
    Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. BMJ case reports · 2022
    Article
  18. Article
  19. COVID-19 and Preeclampsia: Overlapping Features in Pregnancy.Rambam Maimonides medical journal · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Rohit TalwaniDivision of Infectious Diseases, Department of Medicine, Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street Room N150, Baltimore, MD 21201, USA.
Bruce L Gilliam
Charles Howell

Funding

Racial Disparities in Liver DiseasesK24DK072036 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI HOWELL, CHARLES D · 2005 to 2009
$944k
NIDDK NIH HHS K24 DK072036
6 · The paper itself

Abstract

The liver plays an important role in host defense against invasive microorganisms. The effect of microbial pathogens on the liver can vary greatly, presenting with a wide variety of manifestations from asymptomatic increases in aminotransaminases, acute liver failure, hepatic fibrosis, and cirrhosis. In evaluating the liver manifestations of a potential infectious pathogen, diagnosis of some of the less common infectious pathogens is dependent on a high level of suspicion and recognition of some of the key diagnostic clues. Successful diagnosis can only be accomplished through a careful history, including travel and exposures, physical examination, and appropriate microbiologic studies. This article reviews the involvement of the liver during systemic infections with organisms that are not considered to be primarily hepatotropic.

Indexed as

Bacterial InfectionsHumansLiver DiseasesParasitic DiseasesVirus Diseases

Identifiers

PMID21111996
PMCPMC3660095

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.